The DOI matches its Crossref record; the references it cites are not checked yet.
First Identification of an Inherited TPSAB1 Quintuplication in a Patient with Clonal Mast Cell Disease
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the baseline level of tryptase varies depending on the underlying disease and the genetic background.”
From Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome (2019) · cites this paper as [31]
In the citing paper
“over 30% of all patients with myeloid neoplasms, including mastocytosis, have elevated basal tryptase levels.”
From Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome (2019) · cites this paper as [31]
In the citing paper
“an estimated 3–5% of healthy individuals exhibit duplications or multiple copies of the TPSAB1 gene encoding for alpha-tryptase”
From Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome (2019) · cites this paper as [31]
In the citing paper
“when taking the 11.4 threshold as denominator, an increased basal tryptase level is found frequently in otherwise healthy individuals (roughly 5–10% of the general population), in diverse reactive states, and in hematologic disorders, especially in myeloid malignancies (roughly 20–30%; Table 2) [25–31].”
From Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome (2019) · cites this paper as [31]
In the citing paper
“These include tryptase gene replications such as hereditary alpha tryptasemia; chronic infections, such as helminth infections; renal insufficiency – especially hemodialysis patients; and myeloid neoplasms, including myelodysplastic syndromes, SM, acute myeloid leukemia, chronic myeloid leukemia (CML), and chronic eosinophilic leukemia [25–33].”
From Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome (2019) · cites this paper as [31]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 11 · Cited by 73
Metadata
- Authors
- Sabato, V., Chovanec, J., Faber, M., Milner, J. D., Ebo, D., & Lyons, J. J.
- Affiliations
- University of Antwerp (BE)
- National Institutes of Health (US)
- Corresponding author
- Lyons, Jonathan J.
- Venue
- Journal of Clinical Immunology
- Published
- 2018-05
- Volume
- 38
- Issue
- 4
- Pages
- 457-459
- ISSN
- 0271-9142 (ISSN-L)
- 1573-2592
- OpenAlex
- W2801946606
- Cited by
- 73
- References
- 11
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 6 · 2023: 5 · 2022: 15 · 2021: 19 · 2020: 9 · 2019: 8 · 2018: 2
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- AAAAI Foundation / The Mastocytosis Society (Research Award in Mastocytosis and/or Mast Cell Activation Syndrome)
- Fonds Wetenschappelijk Onderzoek (1804518N, 1800614N)
- National Institute of Allergy and Infectious Diseases (DIR)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- TPSAB1, mast cell activation
- MeSH terms
- Alleles, Female, Genotype, Humans, Male, Mastocytosis, Pedigree, Phenotype, Gene Dosage, Genetic Predisposition to Disease, Tryptases, Genetic Association Studies, Clonal Evolution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: First Identification of an Inherited TPSAB1 Quintuplication in a Patient with Clonal Mast Cell Disease. https://app.cochat.ai/papers/10.1007/s10875-018-0506-y
- The paper
- Sabato, V., Chovanec, J., Faber, M., Milner, J. D., Ebo, D., & Lyons, J. J. (2018). First Identification of an Inherited TPSAB1 Quintuplication in a Patient with Clonal Mast Cell Disease. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-018-0506-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.